Feb 16, 2024
Amtagvi receives accelerated approval for certain previously treated adults with unresectable or metastatic melanoma.
Tumor-infiltrating lymphocytes become a commercial cell-therapy approach for a solid tumor. Confirmatory evidence remains a condition of accelerated approval.